Details for Patent: 9,907,756

Which drugs does patent 9,907,756 protect, and when does it expire?

Patent 9,907,756 protects OFEV and is included in one NDA.

Protection for OFEV has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has forty-four patent family members in thirty-five countries.

Summary for Patent: 9,907,756

Title:	Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative
Abstract:	The present invention relates to a suspension formulation containing the active substance 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-a- nilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulph- onate, to a capsule pharmaceutical dosage form containing said suspension formulation, to a process for preparing said suspension formulation, to a process for preparing said capsule comprising said suspension formulation and to the packaging material for the finished capsule.
Inventor(s):	Messerschmid; Roman (Kobe, JP), Binder; Rudolf (Mittelbiberach, DE), Bock; Thomas (Walchwil, CH), Brox; Werner (Beerfelden, DE)
Assignee:	Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)
Application Number:	15/204,277
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,907,756
Patent Claim Types: see list of patent claims	Formulation; Compound; Dosage form;

Drugs Protected by US Patent 9,907,756

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Boehringer Ingelheim	OFEV	nintedanib esylate	CAPSULE;ORAL	205832-001	Oct 15, 2014		RX	Yes	No					Y
Boehringer Ingelheim	OFEV	nintedanib esylate	CAPSULE;ORAL	205832-002	Oct 15, 2014		RX	Yes	Yes					Y

Foreign Priority and PCT Information for Patent: 9,907,756

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	08157748	Jun 6, 2008

International Family Members for US Patent 9,907,756

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	072059
Australia	2009254548
Australia	2015227503
Brazil	PI0913434
Canada	2726267